Suzhou MedicalSystem Technology Co., Ltd. (SHA:603990)
China · Delayed Price · Currency is CNY 19.05
-0.29 (-1.50%)
Oct 8, 2026, 1:15 PM CST
SHA:603990 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,746 | 4,592 | 3,117 | 3,918 | 4,044 | 3,634 | |
Market Cap Growth | 24.74% | 47.29% | -20.43% | -3.12% | 11.27% | -22.31% |
Enterprise Value | 5,498 | 4,606 | 4,470 | 3,925 | 3,511 | 3,097 |
Last Close Price | 19.34 | 15.17 | 10.28 | 12.92 | 14.67 | 13.18 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 334.04 | 117.26 | - | - | 120.50 | 86.63 |
Forward PE | - | 12.33 | 12.33 | 73.83 | 29.41 | 25.32 |
PS Ratio | 20.16 | 15.23 | 6.72 | 6.34 | 13.24 | 10.27 |
PB Ratio | 6.84 | 5.43 | 3.87 | 3.56 | 2.97 | 3.32 |
P/TBV Ratio | 8.60 | 6.78 | 4.76 | 4.00 | 3.19 | 3.55 |
P/FCF Ratio | 179.28 | - | - | - | 155.93 | - |
P/OCF Ratio | 83.54 | 70.20 | - | - | 80.06 | 100.85 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 19.30 | 15.28 | 9.63 | 6.35 | 11.49 | 8.75 |
EV/EBITDA Ratio | 178.34 | 144.12 | - | - | 74.06 | 53.99 |
EV/EBIT Ratio | - | 266.42 | - | - | 105.46 | 70.65 |
EV/FCF Ratio | 171.65 | - | - | - | 135.39 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.27 | 0.33 | 0.52 | 1.56 | 0.12 | 0.07 |
Debt / EBITDA Ratio | 7.33 | 7.36 | - | - | 3.25 | 1.35 |
Debt / FCF Ratio | 7.05 | - | - | - | 6.29 | - |
Net Debt / Equity Ratio | -0.30 | -0.02 | 0.32 | 0.98 | -0.59 | -0.51 |
Net Debt / EBITDA Ratio | -10.19 | -0.56 | -1.65 | -5.56 | -17.05 | -9.77 |
Net Debt / FCF Ratio | -7.99 | 5.67 | -0.99 | -1.17 | -31.16 | 113.22 |
Asset Turnover | 0.23 | 0.14 | 0.13 | 0.22 | 0.21 | 0.25 |
Inventory Turnover | 3.31 | 3.31 | 7.05 | 9.29 | 2.62 | 3.09 |
Quick Ratio | 2.21 | 2.20 | 0.17 | 0.55 | 4.64 | 4.45 |
Current Ratio | 2.37 | 2.32 | 1.27 | 0.66 | 4.81 | 4.70 |
Return on Equity (ROE) | 2.27% | 5.03% | -29.15% | -21.57% | 2.89% | 3.72% |
Return on Assets (ROA) | 0.69% | 0.49% | -3.79% | -4.93% | 1.41% | 1.93% |
Return on Invested Capital (ROIC) | 2.01% | 1.67% | -13.25% | -16.08% | 4.99% | 7.39% |
Return on Capital Employed (ROCE) | 1.50% | 1.90% | -21.40% | -10.60% | 2.40% | 4.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.30% | 0.85% | -8.96% | -6.88% | 0.83% | 1.15% |
FCF Yield | 0.56% | -0.07% | -8.46% | -23.39% | 0.64% | -0.14% |
Payout Ratio | 32.74% | 26.10% | - | - | 10.68% | 39.36% |
Buyback Yield / Dilution | -0.39% | 0.84% | 0.78% | -9.47% | -2.53% | -9.29% |
Total Shareholder Return | -0.39% | 0.84% | 0.78% | -9.47% | -2.53% | -9.29% |